Oligodendrocytes are a Novel Source of Amyloid Peptide Generation (original) (raw)
Glenner GG, Wong CW (1984) Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885–890 ArticleCASPubMed Google Scholar
Goedert M, Wischik CM, Crowther RA et al (1988) Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci USA 85:4051–4055 ArticleCASPubMed Google Scholar
Selkoe DJ (1994) Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer’s disease. Annu Rev Cell Biol 10:373–403 ArticleCASPubMed Google Scholar
Walsh DM, Selkoe DJ (2004) Deciphering the molecular basis of memory failure in Alzheimer’s disease. Neuron 44:181–193 ArticleCASPubMed Google Scholar
Walsh DM, Klyubin I, Fadeeva JV et al (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535–539 ArticleCASPubMed Google Scholar
Meyer-Luehmann M, Spires-Jones TL, Prada C et al (2008) Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease. Nature 451:720–724 ArticleCASPubMed Google Scholar
Billings LM, Oddo S, Green KN et al (2005) Intraneuronal Aβ causes the onset of early Alzheimer’s disease-related cognitive deficits in transgenic mice. Neuron 45:675–688 ArticleCASPubMed Google Scholar
Goedert M (1987) Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer’s disease. EMBO J 6:3627–3632 CASPubMed Google Scholar
Mita S, Schon EA, Herbert J (1989) Widespread expression of amyloid beta-protein precursor gene in rat brain. Am J Pathol 134:1253–1261 CASPubMed Google Scholar
Selkoe DJ, Podlisny MB, Joachim CL et al (1988) β-Amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci USA 85:7341–7345 ArticleCASPubMed Google Scholar
Card JP, Meade RP, Davis LG (1988) Immunocytochemical localization of the precursor protein for β-amyloid in the rat central nervous system. Neuron 1:835–846 ArticleCASPubMed Google Scholar
Kawarabayashi T, Shoji M, Harigaya Y et al (1991) Amyloid β/A4 protein precursor is widely distributed in both the central and peripheral nervous systems of the mouse. Brain Res 552:1–7 ArticleCASPubMed Google Scholar
Beach TG, Walker R, McGeer EG (1989) Patterns of gliosis in Alzheimer’s disease and aging cerebrum. Glia 2:420–436 ArticleCASPubMed Google Scholar
Perlmutter LS, Barron E, Chui HC (1990) Morphologic association between microglia and senile plaque amyloid in Alzheimer’s disease. Neurosci Lett 119:32–36 ArticleCASPubMed Google Scholar
Yamaguchi H, Nakazato Y, Yamazaki T et al (1991) Subpial β/A4 amyloid deposition occurs between astroglial processes in Alzheimer-type dementia. Neurosci Lett 223:217–220 Article Google Scholar
Berkenbosch F, Refolo LM, Fiedrich VL Jr et al (1990) The Alzheimer’s amyloid precursor protein is produced by Type I astrocytes in primary cultures of rat neuroglia. J Neurosci Res 25:431–440 ArticleCASPubMed Google Scholar
Haass C, Hung AY, Selkoe DJ (1991) Processing of β-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion. J Neurosci 11:3783–3793 CASPubMed Google Scholar
Ohyagi Y, Tabira T (1993) Effect of growth factors and cytokines on expression of amyloid beta protein precursor mRNAs in cultured neural cells. Mol Brain Res 18:127–132 ArticleCASPubMed Google Scholar
Garcia-Ladona FJ, Huss Y, Frey P et al (1997) Oligodendrocytes express different isoforms of β-amyloid precursor protein in chemically defined cell culture conditions: in situ hybridization and immunocytochemical detection. J Neurosci Res 50:50–61 ArticleCASPubMed Google Scholar
Mizuguchi M, Ikeda K, Kim SU (1992) Beta-amyloid precursor protein of Alzheimer’s disease in cultured bovine oligodendrocytes. J Neurosci Res 32:34–42 ArticleCASPubMed Google Scholar
Mizuguchi M, Ikeda K, Kim SU (1992) Differential distribution of cellular forms of β-amyloid precursor protein in murine glial cell cultures. Brain Res 584:219–225 ArticleCASPubMed Google Scholar
Palacios G, Palacios JM, Mengod G et al (1992) β-Amyloid precursor protein localization in the Golgi apparatus in neurons and oligodendrocytes. An immunocytochemical structural and ultrastructural study in normal and axotomized neurons. Mol Brain Res 15:195–206 ArticleCASPubMed Google Scholar
Solà C, García-Ladona FJ, Mengod G et al (1993) Increased levels of the Kunitz protease inhibitor-containing βAPP mRNAs in rat brain following neurotoxic damage. Mol Brain Res 17:41–52 ArticlePubMed Google Scholar
Solà C, García-Ladona FJ, Sarasa M et al (1993) βAPP gene expression is increased in the rat brain after motor neuron axotomy. Eur J Neurosci 5:795–808 ArticlePubMed Google Scholar
Guiroy DC, Bogucki A, Papierz W et al (1991) Amyloid β-protein in cerebral amyloid angiopathy, senile plaques, and preamyloidotic lesions in subcortical arteriosclerotic encephalopathy (Binswanger disease). Neurosci Lett 124:31–34 ArticleCASPubMed Google Scholar
Brun A, Englund E (1986) A white matter disorder in dementia of the Alzheimer Type: a pathoanatomical study. Ann Neurol 19:253–262 ArticleCASPubMed Google Scholar
Chia LS, Thompson JE, Moscarello MA (1984) X-ray diffraction evidence for myelin disorder in brain from humans with Alzheimer’s disease. Biochim Biophys Acta 775:308–312 ArticleCASPubMed Google Scholar
London E, de Leon MJ, George AE et al (1986) Periventricular lucencies in the CT scans of aged and demented patients. Biol Psychiatry 21:960–962 ArticleCASPubMed Google Scholar
Hussain I, Hawkins J, Harrison D et al (2007) Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases β-cleavage of amyloid precursor protein and amyloid-β production in vivo. J Neurochem 100:802–809 ArticleCASPubMed Google Scholar
Barten DM, Guss VL, Corsa JA et al (2005) Dynamics of β-amyloid reductions in brain, cerebrospinal fluid, and plasma of β-amyloid precursor protein transgenic mice treated with a γ-secretase inhibitor. J Pharmacol Exp Ther 312:635–643 ArticleCASPubMed Google Scholar
Rosin C, Bates TE, Skaper SD (2004) Excitatory amino acid induced oligodendrocyte cell death in vitro: receptor-dependent and -independent mechanisms. J Neurochem 90:1173–1185 ArticleCASPubMed Google Scholar
Skaper SD, Facci L, Milani D (1990) Culture and use of primary and clonal neural cells. In: Conn PM et al (eds) Methods in neurosciences, vol 2. Academic Press, San Diego, pp 17–33 Google Scholar
Prinjha R, Moore SE, Vinson M et al (2000) Inhibitor of neurite outgrowth in humans. Nature 403:383–384 ArticleCASPubMed Google Scholar
Back SA, Gan X, Li Y et al (1998) Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 18:6241–6253 CASPubMed Google Scholar
Huber AB, Weinmann O, Brösamle C et al (2002) Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci 22:3553–3567 CASPubMed Google Scholar
Taketomi M, Kinoshita N, Kimura K et al (2002) Nogo-A expression in mature oligodendrocytes of rat spinal cord in association with specific molecules. Neurosci Lett 332:37–40 ArticleCASPubMed Google Scholar
Hussain I, Powell D, Howlett DR et al (1999) Identification of a novel aspartic protease (Asp2) as β-secretase. Mol Cell Neurosci 14:419–427 ArticleCASPubMed Google Scholar
Vassar R, Bennett BD, Babu-Khan S et al (1999) β-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735–741 ArticleCASPubMed Google Scholar
Gegelashvili G, Schousboe A, Linnemann D (1994) Expression of amyloid precursor protein (APP) in rat brain and cultured neural cells. Int J Dev Neurosci 12:703–708 ArticleCASPubMed Google Scholar
Golde TE, Estus S, Usiak M et al (1990) Expression of β amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer’s disease using PCR. Neuron 4:253–267 ArticleCASPubMed Google Scholar
Oltersdorf T, Fritz LC, Schenk DB et al (1989) The secreted form of Alzheimer’s amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature 341:144–147 ArticleCASPubMed Google Scholar
Weidemann A, König G, Bunke D et al (1989) Identification, biogenesis, and localization of precursors of Alzheimer’s disease A4 amyloid protein. Cell 57:115–126 ArticleCASPubMed Google Scholar
Kitaguchi N, Takahashi Y, Tokushima Y et al (1988) Novel precursor of Alzheimer’s disease amyloid protein shows protease inhibitory activity. Nature 331:530–532 ArticleCASPubMed Google Scholar
Ponte P, Gonzalez-DeWhitt P, Schilling J et al (1988) A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 331:525–527 ArticleCASPubMed Google Scholar
Lacor PN, Buniel MC, Furlow PW et al (2007) Aβ oligomer-induced aberrations in synapse composition, shape and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J Neurosci 27:796–807 ArticleCASPubMed Google Scholar
Tanzi RE, Bertram L (2005) Twenty years of Alzheimer’s disease amyloid hypothesis: a genetic perspective. Cell 120:545–555 ArticleCASPubMed Google Scholar
Lefranc-Jullien S, Lisowski V, Hernandez JF et al (2005) Design and characterization of a new cell-permeant inhibitor of the β-secretase BACE1. Br J Pharmacol 145:228–235 ArticleCASPubMed Google Scholar
Asai M, Hattori C, Iwata N et al (2006) The novel β-secretase inhibitor KMI-429 reduces amyloid β peptide production in amyloid precursor protein transgenic and wild-type mice. J Neurochem 96:533–540 ArticleCASPubMed Google Scholar
Ghosh AK, Kumaragurubaran N, Hong L et al (2007) Design, synthesis, and X-ray structure of potent memapsin 2 (β-secretase) inhibitors with isophthalamide derivatives as the P2–P3-ligands. J Med Chem 50:2399–2407 ArticleCASPubMed Google Scholar
Nishitomi K, Sakaguchi G, Horikoshi Y et al (2006) BACE1 inhibition reduces endogenous A beta and alters APP processing in wild-type mice. J Neurochem 99:1555–1563 ArticleCASPubMed Google Scholar
Waxman SG (1977) Conduction in myelinated, unmyelinated, and demyelinated fibers. Arch Neurol 34:585–589 CASPubMed Google Scholar
Bartzokis G, Beckson M, Lu PH et al (2001) Age-related changes in frontal and temporal lobe volumes in men. Arch Gen Psychiatry 58:461–465 ArticleCASPubMed Google Scholar
Mesulam MM (1999) Neuroplasticity failure in Alzheimer’s disease: bridging the gap between plaques and tangles. Neuron 24:521–529 ArticleCASPubMed Google Scholar
Felts PA, Baker TA, Smith KJ (1997) Conduction in segmentally demyelinated mammalian central axons. J Neurosci 17:7267–7277 CASPubMed Google Scholar
O’Sullivan M, Jones DK, Summers PE et al (2001) Evidence for cortical “disconnection” as a mechanism of age-related cognitive decline. Neurology 57:632–638 PubMed Google Scholar
Braak H, Del Tredici K, Schultz C et al (2000) Vulnerability of select neuronal types to Alzheimer’s disease. Ann NY Acad Sci 924:53–61 ArticleCASPubMed Google Scholar
Pakkenberg B, Pelvig D, Marner L et al (2003) Aging and the human neocortex. Exp Gerontol 38:95–99 ArticlePubMed Google Scholar
Hu X, Hicks CW, He W et al (2006) Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci 9:1520–1525 ArticleCASPubMed Google Scholar
Hu X, He W, Diaconu C et al (2008) Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves. FASEB J 22:2970–2980 ArticleCASPubMed Google Scholar
Bresnahan JC (1978) An electron-microscopic analysis of axonal alterations following blunt contusion of the spinal cord of the rhesus monkey (Macaca mulatta). J Neurol Sci 37:59–82 ArticleCASPubMed Google Scholar
Miller AK, Alston RL, Corsellis JA (1980) Variation with age in the volumes of grey and white matter in the cerebral hemispheres of man: measurements with an image analyzer. Neuropathol Appl Neurobiol 6:119–132 ArticleCASPubMed Google Scholar
Hinman JD, Abraham CR (2007) What’s behind the decline? The role of white matter in brain aging. Neurochem Res 32:2023–2031 ArticleCASPubMed Google Scholar
Bartzokis G (2004) Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease. Neurobiol Aging 25:5–18 ArticleCASPubMed Google Scholar
Bartzokis G, Beckson M, Lu PH et al (2000) Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research. Psychiatry Res 98:93–102 ArticleCASPubMed Google Scholar
Roth AD, Ramírez G, Alarcón R et al (2005) Oligodendrocytes damage in Alzheimer’s disease: beta amyloid toxicity and inflammation. Biol Res 38:381–387 ArticleCASPubMed Google Scholar
Xu J, Chen S, Ahmed SH et al (2001) Amyloid-β peptides are cytotoxic to oligodendrocytes. J Neurosci 21:RC118 CASPubMed Google Scholar
Lee JT, Xu J, Lee JM et al (2004) Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol 164:123–131 ArticleCASPubMed Google Scholar
Chen S, Lee JM, Zeng C et al (2006) Amyloid beta peptide increases DP5 expression via activation of neutral sphingomyelinase and JNK in oligodendrocytes. J Neurochem 97:631–640 ArticleCASPubMed Google Scholar